株式会社リボルナバイオサイエンス is a startup based in Japan.
株式会社リボルナバイオサイエンス is a startup based in Japan.
株式会社リボルナバイオサイエンス develops small-molecule therapeutics that directly target RNA using a proprietary screening platform (RNA Insight and RNA Domino), focusing initially on rare genetic and neurological diseases and pursuing partnerships with major pharma as well as internal pipeline development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.